Published in Life Sci on July 18, 2003
New atypical antipsychotics for schizophrenia: iloperidone. Drug Des Devel Ther (2010) 0.83
Serotonin 1A receptor agonist increases species- and region-selective adult CNS proliferation, but not through CNTF. Neuropharmacology (2012) 0.81
Newer oral atypical antipsychotic agents: a review. P T (2011) 0.76
Iloperidone-induced ejaculatory dysfunction: A case series. Indian J Psychiatry (2016) 0.76
Influences of CYP2D6(*)10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis. Acta Pharmacol Sin (2016) 0.75
Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci (2005) 1.30
Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors. Neuroendocrinology (2004) 1.06
Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology (2006) 1.04
Study of the calcium dynamics of the human alpha4beta2, alpha3beta4 and alpha1beta1gammadelta nicotinic acetylcholine receptors. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.96
Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. Am J Physiol Endocrinol Metab (2005) 0.95
Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. Br J Pharmacol (2004) 0.93
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission. Eur J Neurosci (2006) 0.89
Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonists. Bioorg Med Chem Lett (2010) 0.88
Pharmacological profile of somatostatin and cortistatin receptors. Mol Cell Endocrinol (2007) 0.88
Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states. Biochemistry (2009) 0.88
Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol (2002) 0.86
Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Eur J Pharmacol (2004) 0.84
Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel. Int J Biochem Cell Biol (2010) 0.84
Toward selective ERbeta agonists for central nervous system disorders: synthesis and characterization of aryl benzthiophenes. J Med Chem (2002) 0.83
Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors. Int J Biochem Cell Biol (2010) 0.83
Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor. Biochemistry (2011) 0.82
Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior. J Biol Chem (2014) 0.82
Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro. Farmaco (2004) 0.82
Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.81
Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel. Neurochem Int (2010) 0.81
Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Neuropharmacology (2005) 0.81
Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors. Biochemistry (2010) 0.80
Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states. Biochim Biophys Acta (2010) 0.80
Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptor. Biochemistry (2010) 0.79
Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors. Neuropharmacology (2005) 0.79
Pharmacological characterisation of the goldfish somatostatin sst5 receptor. Eur J Pharmacol (2002) 0.77
Structural and functional interaction of (±)-2-(N-tert-butylamino)-3'-iodo-4'-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors. Neurochem Int (2012) 0.77
Antagonist effect of pseudohypericin at CRF1 receptors. Eur J Pharmacol (2003) 0.77
Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors. Neurochem Int (2010) 0.76
Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists. Bioorg Med Chem Lett (2009) 0.76
Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states. Int J Biochem Cell Biol (2010) 0.76
Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor. J Pharmacol Exp Ther (2012) 0.75
Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors. Biochemistry (2013) 0.75
Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states. Int J Biochem Cell Biol (2011) 0.75
From ergolines to indoles: improved inhibitors of the human H3 receptor for the treatment of narcolepsy. ChemMedChem (2014) 0.75
Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists. Bioorg Med Chem Lett (2007) 0.75
Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsy. ChemMedChem (2014) 0.75
Ergoline derivatives as highly potent and selective antagonists at the somatostatin sst 1 receptor. Bioorg Med Chem Lett (2007) 0.75
Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists. Bioorg Med Chem Lett (2009) 0.75
(-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. Neurochem Int (2013) 0.75
Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms. Int J Biochem Cell Biol (2013) 0.75